Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 12

1.

Tubular adenoma of the common bile duct with uptake in 18F-FDG PET: A case report.

Hokonohara K, Noda T, Hatano H, Takata A, Hirota M, Oshima K, Tanida T, Komori T, Morita S, Imamura H, Iwazawa T, Akagi K, Hayashi S, Inada M, Adachi S, Dono K.

Mol Clin Oncol. 2016 Jan;4(1):35-38. Epub 2015 Nov 9.

2.

Clinical and biological significance of precursor lesions of intrahepatic cholangiocarcinoma.

Ettel M, Eze O, Xu R.

World J Hepatol. 2015 Nov 8;7(25):2563-70. doi: 10.4254/wjh.v7.i25.2563.

3.

Intraductal papillary neoplasms of the bile duct.

Ohtsuka M, Shimizu H, Kato A, Yoshitomi H, Furukawa K, Tsuyuguchi T, Sakai Y, Yokosuka O, Miyazaki M.

Int J Hepatol. 2014;2014:459091. doi: 10.1155/2014/459091. Epub 2014 May 18. Review.

4.

GNAS and KRAS mutations are common in intraductal papillary neoplasms of the bile duct.

Sasaki M, Matsubara T, Nitta T, Sato Y, Nakanuma Y.

PLoS One. 2013 Dec 2;8(12):e81706. doi: 10.1371/journal.pone.0081706. eCollection 2013.

5.

GNAS codon 201 mutations are uncommon in intraductal papillary neoplasms of the bile duct.

Matthaei H, Wu J, Dal Molin M, Debeljak M, Lingohr P, Katabi N, Klimstra DS, Adsay NV, Eshleman JR, Schulick RD, Kinzler KW, Vogelstein B, Hruban RH, Maitra A.

HPB (Oxford). 2012 Oct;14(10):677-83. doi: 10.1111/j.1477-2574.2012.00504.x. Epub 2012 Jun 18.

6.

Intraductal neoplasm of the intrahepatic bile duct: clinicopathological study of 24 cases.

Naito Y, Kusano H, Nakashima O, Sadashima E, Hattori S, Taira T, Kawahara A, Okabe Y, Shimamatsu K, Taguchi J, Momosaki S, Irie K, Yamaguchi R, Yokomizo H, Nagamine M, Fukuda S, Sugiyama S, Nishida N, Higaki K, Yoshitomi M, Yasunaga M, Okuda K, Kinoshita H, Nakayama M, Yasumoto M, Akiba J, Kage M, Yano H.

World J Gastroenterol. 2012 Jul 28;18(28):3673-80. doi: 10.3748/wjg.v18.i28.3673.

7.

A case of intraductal papillary neoplasm of the bile duct with stromal invasion.

Nanashima A, Sumida Y, Tomoshige K, Takeshita H, Shibata K, Sawai T, Yasutake T, Kinoshita N, Hayashi T, Nakanuma Y, Nagayasu T.

Case Rep Gastroenterol. 2008 Sep 30;2(3):314-20. doi: 10.1159/000154818.

8.

Intra-ampullary papillary-tubular neoplasm (IAPN): characterization of tumoral intraepithelial neoplasia occurring within the ampulla: a clinicopathologic analysis of 82 cases.

Ohike N, Kim GE, Tajiri T, Krasinskas A, Basturk O, Coban I, Bandyopadhyay S, Morohoshi T, Goodman M, Kooby DA, Sarmiento JM, Adsay NV.

Am J Surg Pathol. 2010 Dec;34(12):1731-48. doi: 10.1097/PAS.0b013e3181f8ff05.

9.

Genetics of biliary tract cancers and emerging targeted therapies.

Hezel AF, Deshpande V, Zhu AX.

J Clin Oncol. 2010 Jul 20;28(21):3531-40. doi: 10.1200/JCO.2009.27.4787. Epub 2010 Jun 14. Review.

10.

New advances in the management of biliary tract cancer.

Bridgewater J, Imber C.

HPB (Oxford). 2007;9(2):104-11. doi: 10.1080/13651820701216216.

11.

Pancreatic intraductal papillary-mucinous neoplasms: a new and evolving entity.

Andrejevic-Blant S, Kosmahl M, Sipos B, Klöppel G.

Virchows Arch. 2007 Nov;451(5):863-9. Epub 2007 Sep 27. Review.

12.

Papillary phenotype confers improved survival after resection of hilar cholangiocarcinoma.

Jarnagin WR, Bowne W, Klimstra DS, Ben-Porat L, Roggin K, Cymes K, Fong Y, DeMatteo RP, D'Angelica M, Koea J, Blumgart LH.

Ann Surg. 2005 May;241(5):703-12; discussion 712-4.

Supplemental Content

Support Center